University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
New CRISPR Lab to Accelerate Drug Discovery, Advance Genomic Research

New CRISPR Lab to Accelerate Drug Discovery, Advance Genomic Research

June 14, 2019

GlaxoSmithKline plc (GSK) has launched a five-year, $67 million collaboration with the San Francisco and Berkeley campuses of the University of California to build a state-of-the-art laboratory that will use CRISPR technologies to explore how genes cause disease and to rapidly accelerate the discovery of ...
From Bacteria to Interstellar Travel - with CRISPR in Between - Luke Gilbert Loves Science!

From Bacteria to Interstellar Travel - with CRISPR in Between - Luke Gilbert Loves Science!

June 14, 2019

This week, Luke Gilbert, PhD, Assistant Professor, Department of Urology, and a Goldberg-Benioff Endowed Professor in Prostate Cancer Translational Biology, was named a member of the 2019 class of the Pew-Stewart Scholars Program for Cancer Research. Gilbert was one of seven early-career scientists working ...
Mentorship, Collaboration Inspire a Passion for Improving Outcomes for Older Adults with Cancer

Mentorship, Collaboration Inspire a Passion for Improving Outcomes for Older Adults with Cancer

June 14, 2019

Mentorship within a close-knit community is driving interest in the field of geriatric oncology. Dr. Li-Wen Huang, Hematology Oncology Fellow, and Dr. Melisa Wong, Assistant Professor, Division of Hematology/Oncology, and leader of the new UCSF Older Adult Cancer Care Program, credit key individuals with ...
ASCO 2019 Roundup: A Year for Twitter

ASCO 2019 Roundup: A Year for Twitter

June 14, 2019

Once again UCSF had an impressive presence at this year's annual meeting of the American Society of Clinical Oncologists (ASCO) in Chicago. One of the world’s most prestigious gatherings of oncology professionals, ASCO 2019 drew more than 40,000 cancer experts focusing on groundbreaking research and ...
Podcast: Conquering Cancer from Within. Immunotherapy, the new Hope.

Podcast: Conquering Cancer from Within. Immunotherapy, the new Hope.

May 25, 2019

Dr. Lawrence Fong, leader of the HDFCCC Cancer Immunotherapy Program, was featured last month on the CureTalks podcast for a live discussion of the latest in cancer immunotherapy research, clinical trials, and treatments. Immunotherapy is a type of cancer treatment that helps your immune system ...
The Cigarette and Vape Industry Won't Support this Research, but CTSI Will

The Cigarette and Vape Industry Won't Support this Research, but CTSI Will

May 8, 2019

Tobacco and nicotine research have deep roots at UC San Francisco (UCSF) dating decades back to when the tobacco industry denied the risks of smoking, its causal effects of lung cancer, heart disease and other health problems. A rising number of faculty are dedicated to ...
'Super-Hero' Stem Cells Survive Radiation to Regrow Muscles

'Super-Hero' Stem Cells Survive Radiation to Regrow Muscles

April 18, 2019

Muscle damage is a common side effect of radiation therapy for cancer treatment, and is made worse because the very stem cells responsible for repairing injured muscles typically bear the brunt of radiation damage. Now UC San Francisco researchers have discovered a new type of ...
Three Faculty Elected to American Academy of Arts and Sciences

Three Faculty Elected to American Academy of Arts and Sciences

April 17, 2019

UC San Francisco cancer biologist Alan Ashworth, PhD, structural biologist Yifan Cheng, PhD, and molecular physiologist Holly Ingraham, PhD, have been elected to the American Academy of Arts and Sciences. Ashworth is president of the UCSF Helen Diller Family Comprehensive Cancer Center and E. Dixon Heise Distinguished Professor ...
Training and Mentoring the Next Generation of Cancer Researchers and Providers

Training and Mentoring the Next Generation of Cancer Researchers and Providers

April 16, 2019

Led by Dr. Emily Bergsland, Associate Director of Education for the Helen Diller Family Comprehensive Cancer Center, the Office of Education & Training (OET) aims to connect the UCSF cancer community with education, mentoring, and career development opportunities across all trainee levels. We sat down ...
UCSF Study Aims to Increase Diversity in Cancer Clinical Trials

UCSF Study Aims to Increase Diversity in Cancer Clinical Trials

April 15, 2019

UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities.  The trial will launch this month at UCSF, followed ...